Signal Genetics (SGNL) Enters Agreement with MD Anderson Cancer Center
Tweet Send to a Friend
Signal Genetics, Inc. (NASDAQ: SGNL) announced that the Company has entered into an agreement with the University of Texas MD ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


